Ashley Berkley
Family Medicine · Meyersdale, PANPI 1437395290
Payments from drug & device makers
Across 259 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$725
- Novo Nordisk$359
- GSK$308
- Lilly USA, LLC$292
- E.r. Squibb & Sons, L.L.C.$256
- Abbott$251
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,173100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $725 |
| Novo Nordisk | 22 | $359 |
| GSK | 20 | $308 |
| Lilly USA, LLC | 22 | $292 |
| E.r. Squibb & Sons, L.L.C. | 14 | $256 |
| Abbott | 12 | $251 |
| Pfizer | 17 | $250 |
| AstraZeneca | 15 | $244 |
| Amgen | 15 | $240 |
| Astellas Pharma US Inc | 11 | $235 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $150 |
| Merck | 5 | $96 |
| Exact Sciences | 4 | $94 |
| Boehringer Ingelheim | 5 | $72 |
| Johnson & Johnson | 5 | $69 |
| Dexcom, Inc. | 3 | $61 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $59 |
| Amarin Pharma, Inc. | 3 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Boston Scientific | 2 | $35 |
| UCB, Inc. | 1 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Medtronic(2 entities) | 2 | $30 |
| Novartis | 2 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Mylan Specialty L.p. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
| Sumitomo Pharma America, Inc. | 1 | $1 |
How this compares
$4,189 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 347 | $261,280 |
| MounjaroTirzepatide | 219 | $246,081 |
| TrulicityDulaglutide | 167 | $179,966 |
| JardianceEmpagliflozin | 209 | $154,279 |
| OzempicSemaglutide | 74 | $74,194 |
| XareltoRivaroxaban | 70 | $47,557 |
| Breo ElliptaFluticasone/Vilanterol | 109 | $42,230 |
| MyrbetriqMirabegron | 68 | $41,784 |
| EntrestoSacubitril/Valsartan | 37 | $38,304 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 62 | $35,652 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $30,613 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $25,917 |
| TradjentaLinagliptin | 43 | $23,336 |
| LinzessLinaclotide | 34 | $20,502 |
| Spiriva HandihalerTiotropium Bromide | 27 | $14,257 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $292 | $426,047386 claims |
| PfizerEliquis | $250 | $261,280347 claims |
| Boehringer IngelheimJardiance, Tradjenta | $72 | $177,615252 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta, Arnuity Ellipta | $308 | $87,047198 claims |
| Novo NordiskOzempic | $359 | $74,19474 claims |
| Johnson & JohnsonXarelto, Invokana | $69 | $54,43983 claims |
| Astellas Pharma US IncMyrbetriq | $235 | $41,78468 claims |
| NovartisEntresto | $25 | $38,30437 claims |
| AbbVieLinzess, Synthroid | $725 | $25,713152 claims |
| AstraZenecaBrilinta | $244 | $10,32116 claims |
| MerckJanuvia | $96 | $6,50812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Meyersdale
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.